COVID-19 related Research and Collaborations
Discover the involvement of Novartis in COVID-19 related research and collaborations.
COVID-19 Therapeutics Accelerator
Novartis has joined the accelerator, coordinated by the Bill & Melinda Gates Foundation, Wellcome and Mastercard.
COVID Impacts Cancer Emergency Initiative
Novartis is supporting Conquer Cancer, the ASCO Foundation to allow for better understanding of COVID-19 in cancer care.
ACTIV partnership
Novartis joins the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative.
Innovative Medicines Initiative (IMI)
Novartis is part of a consortium engaging with the Innovative Medicines Initiative (IMI) on their COVID-19 directed efforts.
EFPIA call for therapeutic treatments R&D
Novartis is making available several compounds from our libraries that are considered suitable for in vitro antiviral testing.